Braveheart Bio, Inc. · NASDAQ:BRVE
Braveheart Bio, Inc. shareholders
As of Sep 30, 2026, 60 institutions reported holding Braveheart Bio, Inc., 81.6% of its shares. Largest: Fcpm III Services B.V., Orbimed Advisors LLC and a16z Capital Management, L.L.C. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Braveheart Bio, Inc. | Change | Filed |
|---|---|---|---|---|
| Fcpm III Services B.V. | 21.8M | 24.2% | new | Nov 16, 2026 |
| Orbimed Advisors LLC | 12.2M | 13.5% | new | Nov 16, 2026 |
| a16z Capital Management, L.L.C. | 10.2M | 11.4% | new | Nov 16, 2026 |
| Fidelity | 7.59M | 8.4% | new | Nov 10, 2026 |
| Frazier Life Sciences Management, L.P. | 5.27M | 5.9% | new | Nov 16, 2026 |
| Enavate Sciences Gp, LLC | 3.67M | 4.1% | new | Nov 16, 2026 |
| Capital Group | 2.33M | 2.6% | new | Nov 12, 2026 |
| Avoro Capital Advisors LLC | 1.25M | 1.4% | new | Nov 16, 2026 |
| Vanguard | 1.15M | 1.3% | new | Nov 13, 2026 |
| BlackRock | 1.01M | 1.1% | new | Nov 13, 2026 |